Classes and Prediction of Cell-Penetrating Peptides

Methods in Molecular Biology

Volumn 683, Issue , 2011, Pages 3-19

  Lindgren, Maria ^a   Langel, Ülo ^b,c  

^a Cepep II AB   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c UNIVERSITY OF TARTU   (Estonia)

Author keywords

Cell penetrating peptide; Cellular uptake; Drug delivery; Intracellular delivery; Selective delivery; siRNA

Indexed keywords

CELL PENETRATING PEPTIDE; DRUG CARRIER;

AMINO ACID SEQUENCE; ANIMAL; CELL; CHEMISTRY; CLASSIFICATION; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN TRANSPORT; RESEARCH; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; CELL-PENETRATING PEPTIDES; CELLS; DRUG CARRIERS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN TRANSPORT; RESEARCH;

MLCS; MLOWN;

EID: 79952197259     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-919-2_1     Document Type: Chapter

References (101)

1. Järver, P., and Langel, Ü. (2004) The use of cell-penetrating peptides as a tool for gene regulation. Drug Discov Today 9, 395–402.
2. Joliot, A. (2005) Transduction peptides within naturally occurring proteins. Sci STKE 2005, pe54.
3. Moschos, S. A., Jones, S. W., Perry, M. M., Williams, A. E., Erjefalt, J. S., Turner, J. J., Barnes, P. J., Sproat, B. S., Gait, M. J., and Lindsay, M. A. (2007) Lung delivery studies using siRNA conjugated to TAT(48–60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjug Chem 18, 1450–9.
4. Dupont, E., Prochiantz, A., and Joliot, A. (2007) Identification of a signal peptide for unconventional secretion. J Biol Chem 282, 8994–9000.
5. Hällbrink, M., Florén, A., Elmquist, A., Pooga, M., Bartfai, T., and Langel, Ü. (2001) Cargo deliver y kinetics of cell-penetrating peptides. Biochim Biophys Acta 1515, 101–9.
6. Lindgren, M. E., Hällbrink, M. M., Elmquist, A. M., and Langel, Ü. (2004) Passage of cell-penetrating peptides across a human epithelial cell layer in vitro. Biochem J 377, 69–76.
7. Ma, H. L., Whitters, M. J., Konz, R. F., Senices, M., Young, D. A., Grusby, M. J., Collins, M., and Dunussi-Joannopoulos, K. (2003) IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma. J Immunol 171, 608–15.
8. Joliot, A., Pernelle, C., Deagostini-Bazin, H., and Prochiantz, A. (1991) Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci U S A 88, 1864–8.
9. Derossi, D., Joliot, A. H., Chassaing, G., and Prochiantz, A. (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 269, 10444–50.
10. Derossi, D., Chassaing, G., and Prochiantz, A. (1998) Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol 8, 84–7.
11. Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., and Prochiantz, A. (1996) Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem 271, 18188–93.
12. Ruben, S., Perkins, A., Purcell, R., Joung, K., Sia, R., Burghoff, R., Haseltine, W. A., and Rosen, C. A. (1989) Structural and functional characterization of human immunodeficiency virus tat protein. J Virol 63, 1–8.
13. Vogel, B. E., Lee, S. J., Hildebrand, A., Craig, W., Pierschbacher, M. D., Wong-Staal, F., and Ruoslahti, E. (1993) A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin. J Cell Biol 121, 461–8.
14. Elliot, B. C., Wisnewski, A. V., Johnson, J., Fenwick-Smith, D., Wiest, P., Hamer, D., Kresina, T., and Flanigan, T. P. (1997) In vitro inhibition of Cryptosporidium parvum infection by human monoclonal antibodies. Infect Immun 65, 3933–5.
15. Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R. A., Wingfield, P., and Gallo, R. C. (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67, 277–87.
16. Vives, E., Brodin, P., and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272, 16010–7.
17. Schwarze, S. R., Ho, A., Vocero-Akbani, A., and Dowdy, S. F. (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569–72.
18. Futaki, S., Nakase, I., Tadokoro, A., Takeuchi, T., and Jones, A. T. (2007) Arginine-rich peptides and their internalization mechanisms. Biochem Soc Trans 35, 784–7.
19. Lin, M. L., and Bertics, P. J. (1995) Laminin responsiveness is associated with changes in fibroblast morphology, motility, and anchor-age-independent growth: cell system for examining the interaction between laminin and EGF signaling pathways. J Cell Physiol 164, 593–604.
20. Morris, M. C., Vidal, P., Chaloin, L., Heitz, F., and Divita, G. (1997) A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res 25, 2730–6.
21. Chaloin, L., Vidal, P., Heitz, A., Van Mau, N., Mery, J., Divita, G., and Heitz, F. (1997) Conformations of primary amphipathic carrier peptides in membrane mimicking environments. Biochemistry 36, 11179–87.
22. Zhang, M. Y., Sun, S. C., Bell, L., and Miller, B. A. (1998) NF-kappaB transcription factors are involved in normal erythropoiesis. Blood 91, 4136–44.
23. Chaloin, L., Vidal, P., Lory, P., Mery, J., Lautredou, N., Divita, G., and Heitz, F. (1998) Design of carrier peptide–oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties. Biochem Biophys Res Commun 243, 601–8.
24. Pooga, M., Lindgren, M., Hällbrink, M., Bråkenhielm, E., and Langel, Ü. (1998) Galanin-based peptides, galparan and transportan, with receptor-dependent and independent activities. Ann N Y Acad Sci 863, 450–3.
25. Pooga, M., Hällbrink, M., Zorko, M., and Langel, Ü. (1998) Cell penetration by transportan. FASEB J 12, 67–77.
26. Pooga, M., Soomets, U., Hällbrink, M., Valkna, A., Saar, K., Rezaei, K., Kahl, U., Hao, J. X., Xu, X. J., Wiesenfeld-Hallin, Z., Hökfelt, T., Bartfai, T., and Langel, Ü. (1998) Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol 16, 857–61.
27. Mäe, M., and Langel, Ü. (2006) Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Curr Opin Pharmacol 6, 509–14.
28. Oehlke, J., Scheller, A., Wiesner, B., Krause, E., Beyermann, M., Klauschenz, E., Melzig, M., and Bienert, M. (1998) Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim Biophys Acta 1414, 127–39.
29. Oehlke, J., Krause, E., Wiesner, B., Beyermann, M., and Bienert, M. (1997) Extensive cellular uptake into endothelial cells of an amphipathic beta-sheet forming peptide. FEBS Lett 415, 196–9.
30. Scheller, A., Oehlke, J., Wiesner, B., Dathe, M., Krause, E., Beyermann, M., Melzig, M., and Bienert, M. (1999) Structural requirements for cellular uptake of alpha-helical amphipathic peptides. J Pept Sci 5, 185–94.
31. Deshayes, S., Simeoni, F., Morris, M. C., Divita, G., and Heitz, F. (2007) Peptide-mediated delivery of nucleic acids into mammalian cells. Methods Mol Biol 386, 299–308.
32. Crombez, L., Aldrian-Herrada, G., Konate, K., Nguyen, Q. N., McMaster, G. K., Brasseur, R., Heitz, F., and Divita, G. (2009) A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. Mol Ther 17, 95–103.
33. Duguid, J. G., Li, C., Shi, M., Logan, M. J., Alila, H., Rolland, A., Tomlinson, E., Sparrow, J. T., and Smith, L. C. (1998) A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy. Biophys J 74, 2802–14.
34. Hällbrink, M., Kilk, K., Elmquist, A., Lundberg, P., Lindgren, M., Jiang, Y., Pooga, M., Soomets, U., and Langel, Ü. (2005) Prediction of cell-penetrating peptides. Int J Pept Res Ther 11, 249–59.
35. Lindgren, M., Rosenthal-Aizman, K., Saar, K., Eiriksdottir, E., Jiang, Y., Sassian, M., Stlund, P., Hällbrink, M., and Langel, Ü. (2006) Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. Biochem Pharmacol 71, 416–25.
36. Tünnemann, G., Martin, R. M., Haupt, S., Patsch, C., Edenhofer, F., and Cardoso, M. C. (2006) Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. FASEB J 20, 1775–84.
37. El-Andaloussi, S., Järver, P., Johansson, H. J., and Langel, Ü. (2007) Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study. Biochem J 407, 285–92.
38. Heitz, F., Morris, M. C., and Divita, G. (2009) Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol 157, 195–206.
39. Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., and Rothbard, J. B. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A 97, 13003–8.
40. Rothbard, J. B., Garlington, S., Lin, Q., Kirschberg, T., Kreider, E., McGrane, P. L., Wender, P. A., and Khavari, P. A. (2000) Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat Med 6, 1253–7.
41. Futaki, S. (2002) Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int J Pharm 245, 1–7.
42. Morris, M. C., Depollier, J., Mery, J., Heitz, F., and Divita, G. (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotech 19, 1173–6.
43. Thorén, P. E., Persson, D., Lincoln, P., and Norden, B. (2005) Membrane destabilizing properties of cell-penetrating peptides. Biophys Chem 114, 169–79.
44. Palm, C., Jayamanne, M., Kjellander, M., and Hällbrink, M. (2007) Peptide degradation is a critical determinant for cell-penetrating peptide uptake. Biochim Biophys Acta 1768, 1769–76.
45. Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., and Lebleu, B. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 278, 585–90.
46. Lundberg, M., and Johansson, M. (2002) Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochem Biophys Res Commun 291, 367–71.
47. Vives, E., Richard, J. P., Rispal, C., and Lebleu, B. (2003) TAT peptide internalization: seeking the mechanism of entry. Curr Protein Pept Sci 4, 125–32.
48. Almeida, P. F., and Pokorny, A. (2009) Mechanisms of antimicrobial, cytolytic, and cell-penetrating peptides: from kinetics to thermodynamics. Biochemistry 48, 8083–93.
49. Palm-Apergi, C., Lorents, A., Padari, K., Pooga, M., and Hällbrink, M. (2009) The membrane repair response masks membrane disturbances caused by cell-penetrating peptide uptake. FASEB J 23, 214–23.
50. Futaki, S. (2006) Oligoarginine vectors for intracellular delivery: design and cellular-uptake mechanisms. Biopolymers 84, 241–9.
51. Jones, S. W., Christison, R., Bundell, K., Voyce, C. J., Brockbank, S. M., Newham, P., and Lindsay, M. A. (2005) Characterisation of cell-penetrating peptide-mediated peptide delivery. Br J Pharmacol 145, 1093–102.
52. Duchardt, F., Fotin-Mleczek, M., Schwarz, H., Fischer, R., and Brock, R. (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8, 848–66.
53. Vivés, E. (2003) Cellular uptake [correction of uptake] of the Tat peptide: an endocytosis mechanism following ionic interactions. J Mol Recognit 16, 265–71.
54. Brooks, H., Lebleu, B., and Vivés, E. (2005) Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev 57, 559–77.
55. Nakamura, T., Moriguchi, R., Kogure, K., Shastri, N., and Harashima, H. (2008) Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes. Mol Ther 16, 1507–14.
56. Fittipaldi, A., Ferrari, A., Zoppe, M., Arcangeli, C., Pellegrini, V., Beltram, F., and Giacca, M. (2003) Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J Biol Chem 278, 34141–9.
57. Nakase, I., Niwa, M., Takeuchi, T., Sonomura, K., Kawabata, N., Koike, Y., Takehashi, M., Tanaka, S., Ueda, K., Simpson, J. C., Jones, A. T., Sugiura, Y., and Futaki, S. (2004) Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther 10, 1011–22.
58. Säälik, P., Elmquist, A., Hansen, M., Padari, K., Saar, K., Viht, K., Langel, Ü., and Pooga, M. (2004) Protein cargo delivery properties of cell-penetrating peptides. A comparative study. Bioconjug Chem 15, 1246–53.
59. Foerg, C., Ziegler, U., Fernandez-Carneado, J., Giralt, E., Rennert, R., Beck-Sickinger, A. G., and Merkle, H. P. (2005) Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape. Biochemistry 44, 72–81.
60. Futaki, S., Ohashi, W., Suzuki, T., Niwa, M., Tanaka, S., Ueda, K., Harashima, H., and Sugiura, Y. (2001) Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug Chem 12, 1005–11.
61. Pujals, S., Fernandez-Carneado, J., Kogan, M. J., Martinez, J., Cavelier, F., and Giralt, E. (2006) Replacement of a proline with sil-aproline causes a 20-fold increase in the cellular uptake of a pro-rich peptide. J Am Chem Soc 128, 8479–83.
62. Holm, T., Johansson, H., Lundberg, P., Pooga, M., Lindgren, M., and Langel, Ü. (2006) Studying the uptake of cell-penetrating peptides. Nat Protoc 1, 1001–5.
63. El-Andaloussi, S., Johansson, H. J., Holm, T., and Langel, Ü. (2007) A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids. Mol Ther 15, 1820–6.
64. Hansen, M., Kilk, K., and Langel, Ü. (2008) Predicting cell-penetrating peptides. Adv Drug Deliv Rev 60, 572–9.
65. Liang, J. F., and Yang, V. C. (2005) Synthesis of doxorubicin-peptide conjugate with mul-tidrug resistant tumor cell killing activity. Bioorg Med Chem Lett 15, 5071–5.
66. Ruoslahti, E., Duza, T., and Zhang, L. (2005) Vascular homing peptides with cell-penetrating properties. Curr Pharm Des 11, 3655–60.
67. Laakkonen, P., Akerman, M. E., Biliran, H., Yang, M., Ferrer, F., Karpanen, T., Hoffman, R. M., and Ruoslahti, E. (2004) Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. Proc Natl Acad Sci U S A 101, 9381–6.
68. Myrberg, H., Zhang, L., Mäe, M., and Langel, Ü. (2008) Design of a tumor-homing cell-penetrating peptide. Bioconjug Chem 19, 70–5.
69. Dietz, G. P., and Bahr, M. (2007) Synthesis of cell-penetrating peptides and their application in neurobiology. Methods Mol Biol 399, 181–98.
70. Dietz, G. P., and Bahr, M. (2005) Peptide-enhanced cellular internalization of proteins in neuroscience. Brain Res Bull 68, 103–14.
71. Allinquant, B., Hantraye, P., Mailleux, P., Moya, K., Bouillot, C., and Prochiantz, A. (1995) Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro. J Cell Biol 128, 919–27.
72. Pizzi, M., Sarnico, I., Boroni, F., Benarese, M., Steimberg, N., Mazzoleni, G., Dietz, G. P., Bahr, M., Liou, H. C., and Spano, P. F. (2005) NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity. Cell Death Differ 12, 761–72.
73. Dietz, G. P., Kilic, E., and Bahr, M. (2002) Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction. Mol Cell Neurosci 21, 29–37.
74. Theodore, L., Derossi, D., Chassaing, G., Llirbat, B., Kubes, M., Jordan, P., Chneiweiss, H., Godement, P., and Prochiantz, A. (1995) Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse. J Neurosci 15, 7158–67.
75. Kilic, U., Kilic, E., Dietz, G. P., and Bahr, M. (2004) The TAT protein transduction domain enhances the neuroprotective effect of glial-cell-line-derived neurotrophic factor after optic nerve transection. Neurodegener Dis 1, 44–9.
76. Morris, M. C., Chaloin, L., Heitz, F., and Divita, G. (2000) Translocating peptides and proteins and their use for gene delivery. Curr Opin Biotechnol 11, 461–6.
77. Abes, R., Arzumanov, A. A., Moulton, H. M., Abes, S., Ivanova, G. D., Iversen, P. L., Gait, M. J., and Lebleu, B. (2007) Cell-penetrating-peptide-based delivery of oligonucleotides: an overview. Biochem Soc Trans 35, 775–9.
78. Deshayes, S., Morris, M., Heitz, F., and Divita, G. (2008) Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv Drug Deliv Rev 60, 537–47.
79. Turner, J. J., Ivanova, G. D., Verbeure, B., Williams, D., Arzumanov, A. A., Abes, S., Lebleu, B., and Gait, M. J. (2005) Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells. Nucleic Acids Res 33, 6837–49.
80. Morris, M. C., Gros, E., Aldrian-Herrada, G., Choob, M., Archdeacon, J., Heitz, F., and Divita, G. (2007) A non-covalent peptide-based carrier for in vivo delivery of DNA mimics. Nucleic Acids Res 35, e49.
81. Simeoni, F., Morris, M. C., Heitz, F., and Divita, G. (2005) Peptide-based strategy for siRNA delivery into mammalian cells. Methods Mol Biol 309, 251–60.
82. Meade, B. R., and Dowdy, S. F. (2007) Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Adv Drug Deliv Rev 59, 134–40.
83. Lundberg, P., El-Andaloussi, S., Sutlu, T., Johansson, H., and Langel, Ü. (2007) Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J 21, 2664–71.
84. Mäe, M., El Andaloussi, S., Lundin, P., Oskolkov, N., Johansson, H. J., Guterstam, P., and Langel, Ü. (2009) A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy. J Control Release 134, 221–7.
85. Khafagy El, S., Morishita, M., Isowa, K., Imai, J., and Takayama, K. (2009) Effect of cell-penetrating peptides on the nasal absorption of insulin. J Control Release 133, 103–8.
86. Johnson, L. N., Cashman, S. M., and Kumar-Singh, R. (2008) Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea. Mol Ther 16, 107–14.
87. Eguchi, A., Meade, B. R., Chang, Y. C., Fredrickson, C. T., Willert, K., Puri, N., and Dowdy, S. F. (2009) Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein. Nat Biotechnol 27, 567–71.
88. Vivés, E., Schmidt, J., and Pelegrin, A. (2008) Cell-penetrating and cell-targeting peptides in drug delivery. Biochim Biophys Acta 1786, 126–38.
89. Jiang, T., Olson, E. S., Nguyen, Q. T., Roy, M., Jennings, P. A., and Tsien, R. Y. (2004) Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci U S A 101, 17867–72.
90. Pipkorn, R., Waldeck, W., Spring, H., Jenne, J. W., and Braun, K. (2006) Delivery of substances and their target-specific topical activation. Biochim Biophys Acta 1758, 606–10.
91. Sethuraman, V. A., and Bae, Y. H. (2007) TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. J Control Release 118, 216–24.
92. Aroui, S., Brahim, S., Hamelin, J., De Waard, M., Breard, J., and Kenani, A. (2009) Conjugation of doxorubicin to cell-penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosis. Apoptosis 14, 1352–65.
93. Maxwell, D., Chang, Q., Zhang, X., Barnett, E. M., and Piwnica-Worms, D. (2009) An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging. Bioconjug Chem 20, 702–9.
94. Orive, G., Hernandez, R. M., Rodriguez Gascon, A., Dominguez-Gil, A., and Pedraz, J. L. (2003) Drug delivery in biotechnology: present and future. Curr Opin Biotechnol 14, 659–64.
95. Amantana, A., Moulton, H. M., Cate, M. L., Reddy, M. T., Whitehead, T., Hassinger, J. N., Youngblood, D. S., and Iversen, P. L. (2007) Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate. Bioconjug Chem 18, 1325–31.
96. Pujals, S., Fernandez-Carneado, J., Ludevid, M. D., and Giralt, E. (2008) D-SAP: a new, noncytotoxic, and fully protease resistant cell-penetrating peptide. ChemMedChem 3, 296–301.
97. Neundorf, I., Rennert, R., Franke, J., Kozle, I., and Bergmann, R. (2008) Detailed analysis concerning the biodistribution and metabolism of human calcitonin-derived cell-penetrating peptides. Bioconjug Chem 19, 1596–603.
98. 14C-labeled beta 3-octaarginine in rats. Chem Biodivers 4, 1413–37.
99. Torchilin, V. P. (2007) Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 9, E128–47.
100. Brooks, N. A., Pouniotis, D. S., Tang, C. K., Apostolopoulos, V., and Pietersz, G. A. (2010) Cell penetrating peptides: application in vaccine delivery. Biochim Biophys Acta 1805, 25–34.
101. Lebleu, B., Moulton, H. M., Abes, R., Ivanova, G. D., Abes, S., Stein, D. A., Iversen, P. L., Arzumanov, A. A., and Gait, M. J. (2008) Cell penetrating peptide conjugates of steric block oligonucleotides. Adv Drug Deliv Rev 60, 517–29.